mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.
creator: Tiago Azenha Rama, André Moreira, Mariana Castells
source: The Journal of allergy and clinical immunology
date: 2021